Discover a recent study that found that microultrasonography-guided biopsy could provide an alternative to MRI.

A biomarker, PROSTOX, predicted late genitourinary toxicity accurately in patients with prostate cancer, yielding an area under the curve of 0.76.

Microultrasonography-guided biopsy is as effective as MRI fusion-guided biopsy for detecting Gleason Grade Group 2 or higher prostate cancer, investigators reported during a game-changing trials ...

Micro-ultrasound–guided biopsies were ... who are at increased risk of prostate cancer may safely undergo a micro-ultrasound–guided biopsy rather than an MRI-guided biopsy,” said Adam ...

After a comprehensive two-year follow-up, researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that MRI-guided stereotactic body radiotherapy (SBRT) for prostate cancer ...

To perform prostate cancer biopsies, doctors use a technology called MRI fusion-guided biopsy. This technique combines MRI with a transrectal ultrasound to more precisely sample prostate tissue. The ...

This is a TRUS guided biopsy. It can help to diagnose prostate cancer. You usually have an MRI scan before your TRUS guided biopsy. The MRI scan helps your doctor decide whether you need a biopsy and ...

A UK study found that using a polygenic risk score to identify men at highest genetic risk of prostate cancer significantly ...

The 'game-changing' technology proved just as effective as MRI at diagnosing the disease but was cheaper and easier to use, researchers said. It could allow doctors to provide a 'one-stop shop' where ...

High-resolution microultrasonography-guided biopsy was non-inferior to MRI fusion-guided biopsy for detecting clinically significant prostate cancer (detection rates, 47.1% and 42.6%, respectively ...

guided biopsy with MRI-guided biopsy for prostate cancer. It involved 677 men who underwent biopsy at 19 hospitals across Canada, the U.S. and Europe. Of these, half underwent MRI-guided biopsy ...